COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 194: Articles 1931-1940  | Next

Association between SARS-CoV-2 and Stroke: Perspectives from a metaumbrella-review.
Baldo de Souza, A. M. L., de Araujo, E. F., Pereira, A. C., Junior, N. C., Raimundo, A. C., Meneghim, M. d. C.
10.1101/2024.10.01.24314742 — Posted: 2024-10-03
Delayed viral clearance and altered inflammatory responses resulted in increased severity of SARS-CoV-2 infection in aged mice.
Lacasse, E., Dubuc, I., Gudimard, L., Dos Santos Pereira Andrade, A. C., Gravel, A., Greffard, K., Chamberland, A., Oger, C., Galano, J.-M., Durand, T., Philipe, E., Blanchet, M.-R., Bilodeau, J.-F., Flamand, L.
10.1101/2024.10.03.616431 — Posted: 2024-10-03
Serum proteomics reveals high-affinity and convergent antibodies by tracking SARS-CoV2 hybrid immunity to emerging variants of concern
Patel, A., Lima, T., Carson, R., Huang, Q., Bonissone, S. R., Castellana, N.
10.1101/2024.10.02.616394 — Posted: 2024-10-03
Changing pattern in presentation of infective conjunctivitis during COVID-19 pandemic in a tertiary eye hospital in Nepal
Thinley, T., Gurung, R., Gurung, H. B., Poudel, M., Banjara, P.
10.1101/2024.10.01.24314750 — Posted: 2024-10-02
Greater pericardial and visceral adiposity increase risk of hospitalization or death from SARS-CoV-2 infection in community dwelling adults: A C4R Study
Al-Naamani, N., Balte, P., Shashaty, M., Sharaf, A., Terry, J. G., Carr, J. J., Allison, M. A., Anderson, C. A. M., Bhatt, S., Long, M., Christie, J. D., Oelsner, E. C., Anderson, M. R.
10.1101/2024.10.02.24314721 — Posted: 2024-10-02
Sewer Transport Conditions and Their Role in the Decay of Endogenous SARS-CoV-2 and Pepper Mild Mottle Virus from Source to Collection
Mercier, E., D'Aoust, P. M., Eid, W., Hegazy, N., Kabir, P., Wan, S., Pisharody, L., Renouf, E., Stephenson, S., Grabe, T. E., MacKenzie, A. E., Delatolla, R.
10.1101/2024.10.01.24314490 — Posted: 2024-10-02
Structural basis of SARS-Cov-2 spike recognition by engineered synthetic multivalent VHH antibodies
Lujan Hernandez, A. G., Laughlin, Z. T., Patel, A., Yuan, T. Z., Nugent, R. L., Axelrod, F., Ortlund, E. A., Sato, A. K.
10.1101/2024.10.02.616254 — Posted: 2024-10-02
Sustained exposure to multivalent antigen-decorated nanoparticles generates broad anti-coronavirus responses
Baillet, J., Klich, J. H., Ou, B. S., Meany, E. L., Yan, J., Bruun, T. U. J., Utz, A., Jons, C. K., Lecommandoux, S., Appel, E. A.
10.1101/2024.10.01.616060 — Posted: 2024-10-02
RNA binding protein Musashi1 interacts with the viral genomic RNA and restricts SARS-CoV-2 infection by repressing translation
Ganguli, S., Gupta, D., Ramaswamy, R., Kodumuri, R. V., Krishnan, A. G., Tandel, D., David, D. T., Bunk, S., Chavali, S., Harshan, K. H., Chavali, P. L.
10.1101/2024.09.29.615653 — Posted: 2024-10-02
Bridging Cultures to Defeat COVID-19: An Innovative Virtual Exchange Program in Global Medical Education
Campagna, C. D., Searles, M. P., Suser, J. L., Omar, R. M. K., Bugaigis, H., Mansur, K. M. H., Imragaa, A., Dash, N. R., Saddik, B. W., Shennib, H., Chin, L. S., Perry, S. W.
10.1101/2024.09.30.24314434 — Posted: 2024-10-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).